Opioid Agonist Treatment: January 2021

The Correctional Service of Canada (CSC) introduced methadone over 20 years ago. Since that time, CSC has been providing opioid agonist treatment (OAT) (methadone and buprenorphine-naloxone) to incarcerated persons with an opioid use disorder.

Over the past three years, in the context of the Canadian opioid crisis, the demand for treatment has dramatically increased and continues to increase. The following graph shows a point-in-time snapshot (January 2021) of the number of individuals, by institution, on OAT and the number of individuals on the wait list.

For the Atlantic region:

For the Quebec region:

For the Ontario Region:

For the Prairies region:

For the Pacific Region:

In total, there are 760 on methadone, 1531 on suboxone and 190 on sublocade. The OAT totals are 2481 and there are 476 on waitlist.

Download a printable version of the January 2021 OAT graph.

Download a printable version of the Number of inmates on OAT graph.